 |
PDBsum entry 3qpo
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
3qpo
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.1.4.17
- 3',5'-cyclic-nucleotide phosphodiesterase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a nucleoside 3',5'-cyclic phosphate + H2O = a nucleoside 5'-phosphate + H+
|
 |
 |
 |
 |
 |
nucleoside 3',5'-cyclic phosphate
|
+
|
H2O
|
=
|
nucleoside 5'-phosphate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
J Med Chem
54:4536-4547
(2011)
|
|
PubMed id:
|
|
|
|
|
| |
|
Use of structure-based design to discover a potent, selective, in vivo active phosphodiesterase 10A inhibitor lead series for the treatment of schizophrenia.
|
|
C.J.Helal,
Z.Kang,
X.Hou,
J.Pandit,
T.A.Chappie,
J.M.Humphrey,
E.S.Marr,
K.F.Fennell,
L.K.Chenard,
C.Fox,
C.J.Schmidt,
R.D.Williams,
D.S.Chapin,
J.Siuciak,
L.Lebel,
F.Menniti,
J.Cianfrogna,
K.R.Fonseca,
F.R.Nelson,
R.O'Connor,
M.MacDougall,
L.McDowell,
S.Liras.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |